Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

MICONAZOLE NITRATE POW

Active
SPE2DP-26-T-4382Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

21287 LIGHT INFANTRY AVENUE, FORT BLISS, TX, 79918-2527, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS

Full Description

Show more
MICONAZOLE NITRATE POWDER
MICONAZOLE NITRATE POWDER ANTIFUNGAL FOOT POWDER, 3 OUNCES; 12'S UNIT OF
ISSUE (1) CASE. STORE AT CONTROLLED ROOM TEMPERATURE. STORE IN A COOL
DRY PLACE. STORE AWAY FROM INCOMPATIBLE PRODUCTS.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ001: TAILORED HIGHER LEVEL CONTRACT QUALITY REQUIREMENTS
(MANUFACTURERS AND NON-MANUFACTURERS)
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. Hazard Communication Standard Notice:
Effective June 1, 2015, Federal Standard No. 313-E, Material Safety Data, Transportation Data and Disposal Data for Hazardous Materials Furnished to Government Activities, establishes the requirement for preparation and submission of Safety Data Sheets (SDS) in lieu of Material Safety Data Sheets (MSDS) by suppliers who provide hazardous materials to government activities.
The Occupational Safety and Health Administration (OSHA) has modified its Hazard Communication Standard (HCS) to conform to the United Nations Globally Harmonized System of Classification and Labeling of Chemicals. As a result of this change, GSA revised Federal Standard No. 313-E requiring Safety Data Sheets for classifying chemicals and communicating the applicable information on labels.
In accordance with the revised standard after June 1, 2015:
1. Suppliers will be required to submit, to the contracting officer for review and approval prior to award, safety data sheets consistent with the requirements found at 29 C.F.R. 1910.1200 for hazardous materials delivered to the Government.
2. Suppliers will also be required to submit, to the contracting officer for review and approval prior to award, Hazardous Communication Standard (HCS) labels in accordance with 29 C.F.R. 1910.1200 requirements or
SPE2DP-26-T-4382
SECTION B
current Consumer Product Safety Act (CPSA), Federal Hazardous Substance Act (FHSA) labels when subject to labeling requirements under those statutes. This product labeling is required for hazardous materials delivered to the Government.
3. Finally, suppliers must train their employees on the new safety data sheets, hazardous communication labels, and requirements of 29 C.F.R. 1910.1200.
For more information on SDS, refer to OSHAs website, available at:
https://www.osha.gov/law-regs.html
For information on 29 C.F.R. 1910.1200, refer to the below link:
https://www.osha.gov/dsg/hazcom/index.html RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
UNITED SPIRIT OF AMERICA INC 5QCX2 P/N WARRIOR FTPDR
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017669358 0001 CS 3.000
NSN/MATERIAL:6505016679897
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order.
SPE2DP-26-T-4382
SECTION B
PR: 7017669358 PRLI: 0001 CONT’D
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING
REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W8001Z
0142 CS BN CO A COMPOSITE
1AD SUSTAINMENT BRIGADE SSA
21287 LIGHT INFANTRY AVENUE
FORT BLISS TX 79918-2527
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W8001Z
0142 CS BN CO A COMPOSITE
1AD SUSTAINMENT BRIGADE SSA
21287 LIGHT INFANTRY AVENUE
FORT BLISS TX 79918-2527
US
MARKFOR
W8001Z
0142 CS BN CO A COMPOSITE
1AD SUSTAINMENT BRIGADE SSA
21287 LIGHT INFANTRY AVENUE
FORT BLISS TX 79918-2527
US
M/F: (TCN) W8001Z62090055
RDD: 223
PROJ: TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:07/31/2026
SPE2DP-26-T-4382 NSN/Part Number: 6505-01-667-9897 Quantity: 3 CS Purchase Request: 7017669358QTY: 3 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
DIBBS
BENZOIN TINCTURE, COMPO
Solicitation # SPE2DP-26-T-4356
BENZOIN TINCTURE, COMPOUND, USP is an over-the-counter topical medication for external use only, containing 1000 mg of benzoin resin per milliliter as the active ingredient and 77 percent alcohol as an inactive component. It is packaged in bottles of 16 ounces (473 mL), with a unit of issue defined as one bottle. The product is classified as flammable and must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F), with a non-extendable shelf life of 36 months; at the time of receipt by the first government activity, a minimum of 31 months of shelf life must remain. As a regulated medical product under FDA oversight, it is subject to stringent packaging, labeling, and transport protocols. Packaging must conform to Medical Marking Standard No. 1, superseding MIL-STD-129, and must meet the performance and preservation requirements of MIL-STD-2073-1E. Hazardous materials regulations under 49 CFR, ICAO Technical Instructions, and IMDG Code apply due to its high alcohol content, requiring full compliance with hazardous material shipping standards, including the inclusion of a current Material Safety Data Sheet (MSDS) with every shipment and its electronic submission to DLA.MSDS@DLA.MIL prior to award. The solicitation, issued under contract number SPE2DP-26-T-4356 by the Department of Defense’s Medical Supply Chain Pharm FSA, mandates delivery FOB destination to Ramstein, Germany, with a 20-day delivery period from receipt of order. Proposals must be submitted via the DLA Internet Bid Board System by August 4, 2026. Contractors must comply with a comprehensive set of federal acquisition regulations, including clauses on cybersecurity safeguarding (252.204-7012), prohibitions on certain telecommunications equipment (252.204-7018), transportation restrictions (252.247-7023), employee whistleblower rights, and restrictions on compensating former DoD officials. Invoicing must be processed through the Wide Area WorkFlow system, and all documentation, including packing lists and certifications, must be electronically submitted. The item is subject to inspection and acceptance at the destination by government representatives, governed by FAR 52.246
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
ERYTHROMYCIN OPHTHALMI
Solicitation # SPE2DP-26-T-4394
ERYTHROMYCIN OPHTHALMIC OINTMENT USP is a sterile, topical ointment containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, intended for ophthalmic use only. Each unit is packaged as a single-dose tube containing 3.5 grams of ointment, with 24 tubes per package, defined as the unit of issue. The product must have a minimum of 31 months of remaining shelf life upon receipt by the first government activity, as its total shelf life is 36 months and is non-extendable. Storage requirements mandate controlled room temperature between 15°C and 30°C (59°F–86°F), with protection from excessive heat and freezing. All packaging and labeling must strictly adhere to Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and must comply with DLA’s Master List of Technical and Quality Requirements. The ointment is regulated by the FDA and must be marked and shipped in accordance with commercial packaging standards, specifically ASTM D3951 if not classified as hazardous under FED-STD-313; however, DLA requirements take precedence over all other standards. Each shipment must be delivered FOB destination within five days, using the fastest traceable means, excluding parcel post, to the specified delivery point at Fort Lewis, WA. The product is identified by NSN 6505-01-189-7090, with a single purchase order quantity of one package, and the manufacturer is PADAGIS US LLC under NDC 00574-4024-39.
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LAC
Solicitation # SPE2DP-26-T-4395
RINGER'S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4395 with a total order of 7 packing groups, equivalent to 84 individual units. The product is manufactured by B. Braun Medical Inc. with NDC 00264-7750-00 and is subject to FDA regulation. Packaging must comply strictly with Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and must ensure protection from damage and breakage during transit. Each unit must be sealed and packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost to the specified destination, which is FPO AP 96675. The item has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C), with brief exposure up to 40°C permitted. Packaging must adhere to DLA’s RP001 requirements and the latest DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. No hazard classification applies under FED-STD-313, so commercial packaging per ASTM D3951 is acceptable but subordinate to DLA standards. Delivery is required within 20 days of contract award, with zero quantity variance allowed, and inspection and acceptance occur at the delivery point. The unit of issue is packing group (PG), with each PG containing 12 units. All markings, labeling, and palletization must conform to specified DLA and federal standards, and shipping instructions must follow DLAD Proc Note C19 and C20. The solicitation closed on August 5, 2026, with an original required delivery date of August 3, 2026.
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DOXYCYCLINE HYCLATE
Solicitation # SPE2DP-26-T-4150
Doxycycline Hyclate Tablets, USP equivalent to 100 mg of doxycycline, are supplied in film-coated form as unit packs of 100 tablets per bottle, with the unit of issue defined as a bottle (BT). The contract mandates strict adherence to Medical Marking Standard No. 1A dated February 4, 2013, superseding all references to MIL-STD-129, and requires each unit to be sealed in a container that protects against damage and breakage, while exterior shipping containers must ensure safe, cost-effective delivery by common carriers to the designated destination. All packaging and labeling must conform to DLA’s Technical and Quality Requirements, with hazardous material handling governed by FED-STD-313 and ASTM D3951 only if the item is not classified as hazardous, and DLA’s standards take precedence over commercial standards. The product has a non-extendable shelf life of 36 months and must be stored at controlled room temperature between 20 to 25°C (68 to 77°F), protected from light and moisture. The item is regulated by the FDA, and buyers must submit a referral through EBS to confirm bidder and manufacturer details, including NDC62135-0626-01. The total quantity ordered is eight bottles (8 BT), with delivery required within 20 days FOB destination to Fort Bragg, North Carolina, using traceable shipping methods and prohibiting parcel post. The contract prohibits any variance in quantity, and inspection and acceptance occur at the destination. The shipment must be palletized per RP001 requirements and marked with the specified government identifiers, including the NSN 6505016003042 and project code TP 3, with the supplier identified as CHARTWELL RX LLC.
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 4 days
View Details